Loading...

Neal Hermanowicz

Title(s)Health Sciences Professor, Neurology
Phone(949) 824-6202
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Joshi R, Bronstein JM, Keener A, Alcazar J, Yang DD, Joshi M, Hermanowicz N. PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson's Disease. Front Neurol. 2019; 10:1027. PMID: 31632333.
      View in: PubMed
    2. Paff M, Wang AS, Phielipp N, Vadera S, Morenkova A, Hermanowicz N, Hsu FPK. Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's disease. J Robot Surg. 2019 Sep 13. PMID: 31520275.
      View in: PubMed
    3. Hermanowicz N, Jones SA, Hauser RA. Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey. Neuropsychiatr Dis Treat. 2019; 15:2205-2212. PMID: 31496703.
      View in: PubMed
    4. Lyons KE, Pahwa R, Hermanowicz N, Davis T, Pagan F, Isaacson S. Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin. Expert Rev Clin Pharmacol. 2019 Jul; 12(7):681-691. PMID: 31159608.
      View in: PubMed
    5. Hermanowicz N, Castillo-Shell M, McMean A, Fishman J, D'Souza J. Patient and physician perceptions of disease management in Parkinson's disease: results from a US-based multicenter survey. Neuropsychiatr Dis Treat. 2019; 15:1487-1495. PMID: 31239684.
      View in: PubMed
    6. Hermanowicz N. Neurological commentary addressing the article titled "Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus". CNS Spectr. 2018 12; 23(6):352-354. PMID: 30588904.
      View in: PubMed
    7. Hermanowicz N. Delusional misidentification in Parkinson's disease: report of two cases and a review. Postgrad Med. 2018 Mar; 130(2):280-283. PMID: 29185820.
      View in: PubMed
    8. Hermanowicz N, Alva G, Pagan F, Espay AJ, Patel A, Madrid KC, Kremens D, Kenney J, Arquette S, Tereso G, Lopes M, Farnum C. The Emerging Role of Pimavanserin in the Management of Parkinson's Disease Psychosis. J Manag Care Spec Pharm. 2017 Jun; 23(6-b Suppl):S2-S8. PMID: 28636480.
      View in: PubMed
    9. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88(2):152-159. PMID: 27913695.
      View in: PubMed
    10. Isaacson SH, Fisher S, Gupta F, Hermanowicz N, Kremens DE, Lew MF, Marek K, Pahwa R, Russell DS, Seibyl J. Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective. Expert Rev Neurother. 2017 03; 17(3):219-225. PMID: 27813429.
      View in: PubMed
    11. Hermanowicz S, Hermanowicz N. The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease. Expert Rev Neurother. 2016 06; 16(6):625-33. PMID: 26908168.
      View in: PubMed
    12. Hermanowicz N, Ellenbogen A, Irving G, Buchfuhrer M, Jaros MJ, Shang G, Kim R. The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials. CNS Drugs. 2016 05; 30(5):443-54. PMID: 27095237.
      View in: PubMed
    13. Vadera S, Chan A, Lo T, Gill A, Morenkova A, Phielipp NM, Hermanowicz N, Hsu FP. Frameless Stereotactic Robot-Assisted Subthalamic Nucleus Deep Brain Stimulation: Case Report. World Neurosurg. 2017 Jan; 97:762.e11-762.e14. PMID: 26585721.
      View in: PubMed
    14. Hermanowicz N, Edwards K. Parkinson's disease psychosis: symptoms, management, and economic burden. Am J Manag Care. 2015 Aug; 21(10 Suppl):s199-206. PMID: 26296199.
      View in: PubMed
    15. Hwang GS, Young MT, Hanna MH, Menon G, Phelan M, Carmichael JC, Mills S, Stamos MJ, Hermanowicz N, Pigazzi A. Colorectal surgery in Parkinson's disease--outcomes and predictors of mortality. Int J Colorectal Dis. 2015 Aug; 30(8):1051-8. PMID: 26041022.
      View in: PubMed
    16. Ondo WG, Hermanowicz N, Borreguero DG, Jaros MJ, Kim R, Shang G. Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials. J Clin Mov Disord. 2015; 2:9. PMID: 26788345.
      View in: PubMed
    17. Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014 May; 71(5):543-52. PMID: 24664227.
      View in: PubMed
    18. Solbrig MV, Fan Y, Hermanowicz N, Morgese MG, Giuffrida A. A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats. Exp Neurol. 2010 Nov; 226(1):231-41. PMID: 20832403.
      View in: PubMed
    19. Kölln J, Zhang Y, Thai G, Demetriou M, Hermanowicz N, Duquette P, van den Noort S, Qin Y. Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol. 2010 Aug 01; 185(3):1968-75. PMID: 20610654.
      View in: PubMed
    20. Lyons KE, Friedman JH, Hermanowicz N, Isaacson SH, Hauser RA, Hersh BP, Silver DE, Tetrud JW, Elmer LW, Parashos SA, Struck LK, Lew MF, Pahwa R. Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects. Clin Neuropharmacol. 2010 Jan-Feb; 33(1):5-10. PMID: 19855267.
      View in: PubMed
    21. Cramer SC, Sampat A, Haske-Palomino M, Nguyen S, Procaccio V, Hermanowicz N. Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia. Neurosci Lett. 2010 Jan 01; 468(1):42-5. PMID: 19857550.
      View in: PubMed
    22. Qin Z, Jin Y, Lin S, Hermanowicz NS. A forty-five year follow-up EEG study of Qigong practice. Int J Neurosci. 2009; 119(4):538-52. PMID: 19229721.
      View in: PubMed
    23. Solbrig MV, Hermanowicz N. Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats. J Neurovirol. 2008 May; 14(3):252-60. PMID: 18569459.
      View in: PubMed
    24. Hermanowicz N. Fatal gastroparesis in a patient with Parkinson's disease. Mov Disord. 2008 Jan; 23(1):152-3. PMID: 17987645.
      View in: PubMed
    25. Hermanowicz N. Rasagiline as a therapy for Parkinson's disease (PD). Am J Geriatr Pharmacother. 2007 Jun; 5(2):174-5; author reply 175-6. PMID: 17719520.
      View in: PubMed
    26. Hermanowicz N. Drug therapy for Parkinson's disease. Semin Neurol. 2007 Apr; 27(2):97-105. PMID: 17390254.
      View in: PubMed
    27. Grant AC, Hermanowicz N. Reduction of EEG myogenic artifact with botulinum toxin during video-EEG monitoring. Epilepsia. 2007 Feb; 48(2):324-9. PMID: 17295626.
      View in: PubMed
    28. Kolln J, Ren HM, Da RR, Zhang Y, Spillner E, Olek M, Hermanowicz N, Hilgenberg LG, Smith MA, van den Noort S, Qin Y. Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol. 2006 Oct 15; 177(8):5652-8. PMID: 17015754.
      View in: PubMed
    29. Hermanowicz N. A blind man with Parkinson's disease, visual hallucinations, and Capgras syndrome. J Neuropsychiatry Clin Neurosci. 2002; 14(4):462-3. PMID: 12426417.
      View in: PubMed
    30. Hermanowicz N. Management of Parkinson's disease. Strategies, pitfalls, and future directions. Postgrad Med. 2001 Dec; 110(6):15-8, 21-3, 28. PMID: 11787405.
      View in: PubMed
    31. Harrington DL, Haaland KY, Hermanowicz N. Temporal processing in the basal ganglia. Neuropsychology. 1998 Jan; 12(1):3-12. PMID: 9460730.
      View in: PubMed
    32. Haaland KY, Harrington DL, O'Brien S, Hermanowicz N. Cognitive-motor learning in Parkinson's disease. Neuropsychology. 1997 Apr; 11(2):180-6. PMID: 9110325.
      View in: PubMed
    33. Hermanowicz N, Truong DD. Development of botulinum toxin therapy. West J Med. 1995 Nov; 163(5):472-3. PMID: 8533413.
      View in: PubMed
    34. Hermanowicz N, Truong DD. Treatment of oromandibular dystonia with botulinum toxin. Laryngoscope. 1991 Nov; 101(11):1216-8. PMID: 1943423.
      View in: PubMed
    35. Truong DD, Dubinsky R, Hermanowicz N, Olson WL, Silverman B, Koller WC. Posttraumatic torticollis. Arch Neurol. 1991 Feb; 48(2):221-3. PMID: 1993013.
      View in: PubMed
    36. Truong DD, Hermanowicz N, Rontal M. Botulinum toxin in treatment of tardive dyskinetic syndrome. J Clin Psychopharmacol. 1990 Dec; 10(6):438-9. PMID: 2286715.
      View in: PubMed
    37. Truong DD, Hermanowicz N, Mistura K. Rabbit syndrome treated with botulin. South Med J. 1990 Jul; 83(7):854-5. PMID: 2371612.
      View in: PubMed
    38. Truong DD, Hermanowicz NS. Clinical evaluation of bidirectional torticollis. Mov Disord. 1990; 5(2):181. PMID: 2325686.
      View in: PubMed
    39. Manna C, Hermanowicz N, Ro JY, Neilan B, Glushko V, Kim S. Abnormal membrane protein methylation and merocyanine 540 fluorescence in sickle erythrocyte membranes. Biochem Med. 1984 Jun; 31(3):362-70. PMID: 6477541.
      View in: PubMed
    40. Williamson P, Bateman J, Kozarsky K, Mattocks K, Hermanowicz N, Choe HR, Schlegel RA. Involvement of spectrin in the maintenance of phase-state asymmetry in the erythrocyte membrane. Cell. 1982 Oct; 30(3):725-33. PMID: 7139713.
      View in: PubMed